MAPT and supranuclear palsy, progressive, 1: Most heterogeneity in underlying primary neuropathology was seen in CBS; 10 patients had FTLD-tau (CBD), 8 had FTLD-tau (PSP), 1 had FTLD-tau (Pick disease), 1 had FTLD-TDP, and 1 lacked evidence of neurodegeneration.